PDS Biotechnology Corp.
PDSB:NASDAQ
PDS Biotechnology is a clinical stage immuno-oncology company with a growing pipeline of clinical-stage immunotherapies to treat various HPV-associated cancers, including head and neck cancer, cervical and anal cancers.
Streetwise Company Fact Sheet2025/3/6 1:31:29
(PDSB:NASDAQ)
Analyst coverage
| Cantor Fitzgerald — Louise Chen |
| B. Riley Securities — Mayank Mamtani |
| Alliance Global Partners — James Molloy |
| H.C. Wainwright & Co. — Dr. Joseph Pantginis |
Streetwise Reports Articles
| 10/02/2024 - View Article |
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
